Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Buprenorphine, Naloxone Drug Combination MeSH Descriptor Data 2025


MeSH Heading
Buprenorphine, Naloxone Drug Combination
Tree Number(s)
D03.132.577.249.150.500
D03.132.577.249.706.275
D03.605.497.150.500
D03.605.497.750.275
D03.633.400.686.150.500
D03.633.400.686.750.275
D04.615.723.795.150.500
D04.615.723.795.706.275
D26.310.352
Unique ID
D000069479
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069479
Scope Note
A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESICS with naloxone, a NARCOTIC ANTAGONISTS to reduce the potential for NARCOTIC DEPENDENCE in the treatment of pain. It may also be used for OPIOID SUBSTITUTION THERAPY.
Entry Term(s)
Buprenorphine Naloxone
Buprenorphine Naloxone Drug Combination
Buprenorphine-Naloxone
Buprenorphine-Naloxone Combination
Buprenorphine-Naloxone Drug Combination
Suboxone
Pharm Action
Analgesics, Opioid
Narcotic Antagonists
Registry Numbers
0
Public MeSH Note
2016; BUPRENORPHINE, NALOXONE DRUG COMBINATION was indexed under BUPRENORPHINE and NALOXONE 2006-2015
History Note
2016 (2006)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2019/03/27
Buprenorphine, Naloxone Drug Combination Preferred
Suboxone Narrower
page delivered in 0.138s